LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
The United States has delivered the first doses of Lenacapavir, a new long-acting HIV prevention drug, to Eswatini and Zambia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback